Australia - angielski - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - 11677 - enteral feeding kit - the abbvie j is intended to provide long-term enteral access for administration of medication to the small intestine. the abbvie j is indicated for the administration of the medication duodopa (levodopa/carbidopa) intestinal gel.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - 35419 - tube, feeding, gastrostomy - the abbvie peg is intended to provide long-term enteral access for administration of medication to the small intestine when used in conjunction with the abbvie j intestinal tube. as needed, enteral nutrition may be administered directly to the stomach in parallel with medication delivery to the intestine. the abbvie peg is indicated for the administration of the medication duodopa (levodopa/carbidopa) intestinal gel.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - 16798 - tube, feeding, nasoenteral - the abbvie nj is intended to provide short-term enteral access for the administration of medicine to the small intestine. the abbvie nj is indicated for the administration of the medication duodopa (levodopa/carbidopa intestinal gel).

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

abbvie limited - venetoclax 10mg;  ; venetoclax 50mg; venetoclax 100mg - film coated tablet - active: venetoclax 10mg   excipient: calcium hydrogen phosphate colloidal silicon dioxide copovidone opadry ii yellow 85f32450 polysorbate 80 purified water sodium stearyl fumarate active: venetoclax 50mg excipient: calcium hydrogen phosphate colloidal silicon dioxide copovidone opadry ii beige 85f97497 polysorbate 80 purified water sodium stearyl fumarate active: venetoclax 100mg excipient: calcium hydrogen phosphate colloidal silicon dioxide copovidone opadry ii yellow 85f32450 polysorbate 80 purified water sodium stearyl fumarate - venclexta is indicated for the treatment of patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

abbvie limited - venetoclax 10mg;   - film coated tablet - 10 mg - active: venetoclax 10mg   excipient: calcium hydrogen phosphate colloidal silicon dioxide copovidone opadry ii yellow 85f32450 polysorbate 80 purified water sodium stearyl fumarate - venclexta is indicated for the treatment of patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

abbvie limited - venetoclax 100mg;   - film coated tablet - 100 mg - active: venetoclax 100mg   excipient: calcium hydrogen phosphate colloidal silicon dioxide copovidone opadry ii yellow 85f32450 polysorbate 80 purified water sodium stearyl fumarate - venclexta is indicated for the treatment of patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

abbvie limited - venetoclax 50mg;   - film coated tablet - 50 mg - active: venetoclax 50mg   excipient: calcium hydrogen phosphate colloidal silicon dioxide copovidone opadry ii beige 85f97497 polysorbate 80 purified water sodium stearyl fumarate - venclexta is indicated for the treatment of patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).

Malezja - angielski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbvie sdn bhd - venetoclax -

Malezja - angielski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbvie sdn bhd - venetoclax -

Malezja - angielski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbvie sdn bhd - venetoclax -